A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model von Franke, Deanna D.H., Yolcu, Esma S., Alard, Pascale, Kosiewicz, Michele M., Shirwan, Haval

Volltext

Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice von Franke, Deanna D. H., Shirwan, Haval

Volltext

Ex Vivo Expansion of CD4 super(+)CD25 super(+)FoxP3 super(+) T Regulatory Cells Based on Synergy between IL-2 and 4-1BB Signaling von Elpek, Kutlu G, Yolcu, Esma S, Franke, Deanna DH, Lacelle, Chantale, Schabowsky, Rich-Henry, Shirwan, Haval

Volltext

IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future von Franke, Deanna DH, Shirwan, Haval

Volltext